Scenic Biotech Extends Research Collaboration with Bristol Myers Squibb

June 12, 2025 – We’re thrilled to announce the extension of our research collaboration with Bristol Myers Squibb! The growth of this partnership highlights the unique power of our Cell-Seq™ platform, which unlocks the underlying genetic interactions of cellular pathways for novel drug targets.

Together, we are working to identify target biology for indication selection, and expansion, driving progress towards novel treatments for severe diseases. It’s a testament to the productive collaboration and shared vision between our teams.

In parallel to advancing our proprietary pipeline in neuro- and metabolic diseases, we remain committed to supporting our partners in shaping the future of medicine and improving patient outcomes. We look forward to the continued progress we’ll make together!

To the original announcement: https://scenicbiotech.com/blog/scenic-biotech-enters-into-research-collaboration-with-bristol-myers-squibb/